BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33713085)

  • 1. Hypercalcemia in the nephrology department patients - incidence, etiology and impact on renal function.
    Królewicz K; Steć Z; Niemczyk S
    Pol Merkur Lekarski; 2021 Feb; 49(289):9-12. PubMed ID: 33713085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe hypercalcemia requiring acute hemodialysis: A retrospective cohort study with increased incidence during the Covid-19 pandemic.
    Bentata Y; Benabdelhak M; Haddiya I; Oulali N; Housni B
    Am J Emerg Med; 2022 Jan; 51():374-377. PubMed ID: 34823193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia in the ED: prevalence, etiology, and outcome.
    Lindner G; Felber R; Schwarz C; Marti G; Leichtle AB; Fiedler GM; Zimmermann H; Arampatzis S; Exadaktylos AK
    Am J Emerg Med; 2013 Apr; 31(4):657-60. PubMed ID: 23246111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcemia and acute kidney injury induced by eldecalcitol in patients with osteoporosis: a case series of 32 patients at a single facility.
    Aihara S; Yamada S; Oka H; Kamimura T; Nakano T; Tsuruya K; Harada A
    Ren Fail; 2019 Nov; 41(1):88-97. PubMed ID: 30909788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Intravenous Pamidronate for Parathyroid Hormone-dependent Hypercalcemia in Hospitalized Patients.
    Rosenblum RC; Twito O; Barzilay-Yoseph L; Ramaty E; Klein N; Rotman-Pikielny P
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4593-e4602. PubMed ID: 34157125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of hypercalcaemic crisis in adults: Current role of renal replacement therapy.
    Bentata Y; El Maghraoui H; Benabdelhak M; Haddiya I
    Am J Emerg Med; 2018 Jun; 36(6):1053-1056. PubMed ID: 29631925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Etiological Profile of Hypercalcemia in Hospitalized Adult Patients and Association with Mortality.
    Sulaiman S; Mukherjee S; Sharma S; Pal R; Bhadada SK
    Indian J Endocrinol Metab; 2022; 26(5):453-458. PubMed ID: 36618516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Low-Calcium Hemodialysis in the Treatment of Hypercalcemic Crisis.
    Trabulus S; Oruc M; Ozgun E; Altiparmak MR; Seyahi N
    Nephron; 2018; 139(4):319-331. PubMed ID: 29672319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of hospitalized patients with hypercalcemia in the province of Malaga: a longitudinal, retrospective, multicenter study.
    Ropero-Luis G; López-Sampalo A; Sanz-Cánovas J; Ruiz-Cantero A; Gómez-Huelgas R
    Rev Clin Esp (Barc); 2023 Oct; 223(8):486-492. PubMed ID: 37532015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal failure and hypercalcemia.
    Moysés-Neto M; Guimarães FM; Ayoub FH; Vieira-Neto OM; Costa JA; Dantas M
    Ren Fail; 2006; 28(2):153-9. PubMed ID: 16538974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic Hypercalcemia in Patients with Primary Hyperparathyroidism Is Associated with Severity of Disease, Polypharmacy, and Comorbidity.
    Aresta C; Passeri E; Corbetta S
    Int J Endocrinol; 2019; 2019():7617254. PubMed ID: 32082374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes of hypercalcemia in a population of military veterans in the United States.
    Newman EM; Bouvet M; Borgehi S; Herold DA; Deftos LJ
    Endocr Pract; 2006; 12(5):535-41. PubMed ID: 17002928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INCREASED SERUM CALCIUM IS NOT COMMON IN HOSPITALIZED PATIENTS WITH PRIMARY HYPERPARATHYROIDISM: A RETROSPECTIVE, OBSERVATIONAL STUDY.
    Tailakh MA; Yahia A; Polischuck I; Liel Y
    Endocr Pract; 2020 Mar; 26(3):285-290. PubMed ID: 31859546
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a 24-hour infusion of etidronate disodium for the treatment of hypercalcemia of malignancy.
    Flores JF; Rude RK; Chapman RA; Belani CP; Chang AY; Pritchard JD; Hoff JV
    Cancer; 1994 May; 73(10):2527-34. PubMed ID: 8174049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Short-Term Vitamin D Supplementation on Calcium Status in Vitamin D Insufficient Renal Transplant Recipients at Risk of Hypercalcemia.
    Lynch Cronin I; Byrne F; Doyle R; Fraser WD; Chipchase A; Eustace JA
    J Ren Nutr; 2019 May; 29(3):181-187. PubMed ID: 30691727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and outcome of severe hypercalcemia on admission to the emergency department: a retrospective cohort study.
    Ravioli S; Lafranchi A; Exadaktylos AK; Haidinger M; Lindner G
    Swiss Med Wkly; 2023 Apr; 153():40069. PubMed ID: 37191138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.
    Press DM; Siperstein AE; Berber E; Shin JJ; Metzger R; Monteiro R; Mino J; Swagel W; Mitchell JC
    Surgery; 2013 Dec; 154(6):1232-7; discussion 1237-8. PubMed ID: 24383100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Hyperparathyroidism Presenting as Posterior Reversible Encephalopathy Syndrome: A Report of Two Cases.
    Pal R; Dutta A; Agrawal K; Jain N; Dutta P; Bhansali A; Behera A; Bhadada SK
    J Clin Res Pediatr Endocrinol; 2020 Nov; 12(4):432-438. PubMed ID: 32129057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD.
    Coyne DW; Goldberg S; Faber M; Ghossein C; Sprague SM
    Clin J Am Soc Nephrol; 2014 Sep; 9(9):1620-6. PubMed ID: 24970869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.